NovaBridge Biosciences (NBP) insider trading
Every open-market stock purchase and sale by NovaBridge Biosciences executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Sean Wuxiong Cao (Officer) and 2 others sold $88.3K in the last 90 days.
- Last insider buy: Mark Arnold Hagler (Insider), $577K, 6 months ago.
Last 12 months: insiders bought $577K (1 buy) and sold $154K (7 sales). Last close $1.33 on Oct 22, 2026.
Recent NBP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 15, 2026 | Ian Ying Woo (Insider) | Bought (not open market) | — |
| Oct 15, 2026 | Ian Ying Woo (Insider) | Bought (not open market) | — |
| Sep 18, 2026 | Phillip Andrew Dennis (C-suite exec) | Sold | $5.8K |
| Sep 17, 2026 | Phillip Andrew Dennis (C-suite exec) | Bought (not open market) | — |
| Sep 17, 2026 | Phillip Andrew Dennis (C-suite exec) | Bought (not open market) | — |
| Sep 9, 2026 | Sean Wuxiong Cao (Officer) | Sold | $79.9K |
| Sep 3, 2026 | Sean Wuxiong Cao (Officer) | Bought (not open market) | — |
| Sep 3, 2026 | Sean Wuxiong Cao (Officer) | Bought (not open market) | — |
| Sep 3, 2026 | Sean Wuxiong Cao (Officer) | Bought (not open market) | — |
| Sep 3, 2026 | Sean Wuxiong Cao (Officer) | Bought (not open market) | — |
| Aug 31, 2026 | Cong Claire Xu (VP) | Sold | $2.6K |
| Aug 30, 2026 | Cong Claire Xu (VP) | Bought (not open market) | — |
| Aug 30, 2026 | Cong Claire Xu (VP) | Bought (not open market) | — |
| Aug 22, 2026 | Robert A. Lenz (Insider) | Bought (not open market) | — |
| Aug 22, 2026 | Robert A. Lenz (Insider) | Bought (not open market) | — |
| Jul 8, 2026 | Mark Arnold Hagler (C-suite exec) | Bought (not open market) | — |
| Jul 8, 2026 | Liwei Lorraine Lin (General Counsel) | Bought (not open market) | — |
| Jul 6, 2026 | Cong Claire Xu (VP) | Sold | $4K |
| Jul 6, 2026 | Srishti Gupta (CEO) | Bought (not open market) | — |
| Jul 4, 2026 | Cong Claire Xu (VP) | Bought (not open market) | — |
| Jul 4, 2026 | Cong Claire Xu (VP) | Bought (not open market) | — |
| Jun 29, 2026 | Wei Fu (Insider) | Bought (not open market) | — |
| Jun 29, 2026 | Wei Fu (Insider) | Bought (not open market) | — |
| Jun 29, 2026 | Wei Fu (Insider) | Bought (not open market) | — |
| Jun 22, 2026 | Sean Wuxiong Cao (Officer) | Bought (not open market) | — |
Who's trading NBP
- Ian Ying Woo, Insider: other filings, last Oct 15, 2026
- Phillip Andrew Dennis, C-suite exec: sold $11.4K (2 sales), last Sep 18, 2026
- Sean Wuxiong Cao, Officer: sold $122K (2 sales), last Sep 9, 2026
- Cong Claire Xu, VP: sold $20.4K (3 sales), last Aug 31, 2026
- Robert A. Lenz, Insider: other filings, last Aug 22, 2026
- Mark Arnold Hagler, C-suite exec: bought $577K (1 buy), last Jul 8, 2026
- Liwei Lorraine Lin, General Counsel: other filings, last Jul 8, 2026
- Srishti Gupta, CEO: other filings, last Jul 6, 2026
- Wei Fu, Insider: other filings, last Jun 29, 2026
Get free alerts when an insider at NovaBridge Biosciences files a new trade →